GLOBAL TYROSINE KINASE JAK INHIBITORS MARKET 2018 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2023

Sep 2018 132

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
These inhibitors have therapeutic application in the treatment of cancer and inflammatory diseases such as rheumatoid arthritis. There is interest in their use for various skin conditions. JAK3 inhibitors are attractive as a possible treatment of various autoimmune diseases since its functions is mainly restricted to lymphocytes. Development for a selective JAK3 inhibitors are ongoing.
In the report, we only count drugs for human beings. And the 1 unit is 1 tablet.
Scope of the Report:
This report focuses on the Tyrosine Kinase JAK Inhibitors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Tyrosine Kinase JAK Inhibitors is widely used in Rheumatoid Arthritis (RA), Polycythemia Vera (PCV) and Myelofibrosis (MF). The most proportion of Tyrosine Kinase JAK Inhibitors is for Rheumatoid Arthritis (RA), and the proportion in 2017 is about 37%.
North America is the largest consumption place, with a consumption market share nearly 56% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 39%.
The worldwide market for Tyrosine Kinase JAK Inhibitors is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Pfizer
- Incyte
- Novartis
- Eli Lilly
- Gilead
- Sanofi
- Galapagos
- AbbVie
- Vertex
- Teva
- Astellas Pharma
- Celgene
- CTI BioPharma
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Tofacitinib
- Ruxolitinib
- Baricitinib
Market Segment by Applications, can be divided into
- Rheumatoid Arthritis (RA)
- Polycythemia Vera (PCV)
- Myelofibrosis (MF)
- Others
There are 15 Chapters to deeply display the global Tyrosine Kinase JAK Inhibitors market.
Chapter 1, to describe Tyrosine Kinase JAK Inhibitors Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Tyrosine Kinase JAK Inhibitors, with sales, revenue, and price of Tyrosine Kinase JAK Inhibitors, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Tyrosine Kinase JAK Inhibitors, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Tyrosine Kinase JAK Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Tyrosine Kinase JAK Inhibitors sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

Related reports :

(Aug 19)

Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Rese...

(Aug 19)

Catalase is a common enzyme found in nearly all living organisms exposed to oxygen (such as bacteria, plants, and animals).It catalyzes the ...

(Aug 19)

Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological sam...

(Aug 19)

DNA polymerase is an enzyme that synthesizes DNA molecules from deoxyribonucleotides, the building blocks of DNA. These enzymes are essentia...

(Aug 19)

Proteomics is the study of the structure and functions of proteins that are used in drug discovery, diagnosis, and treatment of diseases. A ...

(Jul 19)

Avalanche airbags are safety gear designed to prevent the wearer from being buried while skiing and mountaineering. In an avalanche, larger ...

GLOBAL TYROSINE KINASE JAK INHIBITORS MARKET 2018 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2023

Global Info Research

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Biotechnology market as per your needs. Get the best of Biotechnology research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

Buy Any Report Avail 15% Discount. Coupon Code: SEP15

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy